Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

GRISACTIN ULTRA

GRISEOFULVIN, ULTRAMICROCRYSTALLINE

Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview GRISACTIN ULTRA is listed in Drugs@FDA under application 062178 (ANDA).

Marketing status: Discontinued Active ingredient GRISEOFULVIN, ULTRAMICROCRYSTALLINE Form and strength TABLET;ORAL - 250MG Sponsor WYETH AYERST Submission history Latest submission status date: 1994-01-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview GRISACTIN ULTRA is listed in Drugs@FDA under application 062178 (ANDA). Marketing status: Discontinued Active ingredient GRISEOFULVIN, ULTRAMICROCRYSTALLINE Form and strength TABLET;ORAL - 250MG Sponsor WYETH AYERST Submission history Latest submission status date: 1994-01-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.